ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3043

Dense Genotyping of Immune Related Loci in a Multi-Ethnic Behçet’s Disease Cohort Identifies Genetic Associations in a Long Noncoding RNA Near QSOX2, RASIP1/FUT2, and IL12A-AS1

Paul Renauer1, Patrick Coit1, Travis Hughes2, Mikhail Ognenovski1, Adam Adler3, Lourdes Ortiz-Fernández4, Vuslat Yilmaz5, Kenan Aksu6, Nursen Duzgun7, Gokhan Keser8, Ayse Cefle9, Ayten Yazici10, Andac Ergen11, Erkan Alpsoy12, Carlo Salvarani13, Bruno Casali14, Ina Koetter15, Alexandra Zhernakova16, Cisca Wijmenga17, Fujio Takeuchi18, Shinji Harihara19, Toshikatsu Kaburaki20, Yeong Wook Song21, Francisco David Carmona22, Marta E. Alarcon Riquelme23, Javier Martín22, Güher Saruhan-Direskeneli24, María Francisca Gonzalez Escribano25, Haner Direskeneli26 and Amr H Sawalha1, 1Division of Rheumatology, University of Michigan, Ann Arbor, MI, 2Division of Health Sciences and Technology, Harvard Medical School, Boston, MA, 3Oklahoma Medical Research Foundation, OK, OK, 4Immunology department, Hospital Universitario Virgen del Rocío, Sevilla, Spain, 5Istanbul University, Istanbul Faculty of Medicine, Department of Physiology, Istanbul, Turkey, 6İnternal Medicine Division of Rheumatology, Ege University Medical Faculty, Izmir, Turkey, 7Internal Medicines, Rheumatology Department, Ankara University School of Medicine, Ankara, Turkey, 8Rheumatology, Ege University Medical Faculty, Izmir, Turkey, 9Rheumatology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey, 10Rheumatology, Kocaeli University School of Medicine, Kocaeli, Turkey, 11Okmeydaný Research and Education Hospital, Istanbul, Turkey, 12Department of Dermatology, Akdeniz University School of Medicine, Antalya, Turkey, 13Rheumatology, Azienda Ospedaliera ASMN, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy, 14Molecular Biology Laboratory, Azienda Ospedaliera Arcispedale Santa Maria Nuova, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy, 15Internal Medicine IV Rheumatology, Asklepios Klinik Altona, Hamburg, Germany, 16Rheumatology and Clinical Immunology, University of Groningen, University Medical Center, Groningen, Netherlands, 17Genetics, University Medical Hospital Groningen, University of Groningen, Groningen, Netherlands, 18#504 Lab/ Dep of Internal Medicine (Allergy & Rheumatology), Faculty of Medicine, University of Toyko, Tokyo, Japan, 19Division of Anthropology, Department of Biological Science, The University of Tokyo Graduate School of Science, Tokyo, Japan, 20Ophthalmology, The University of Tokyo School of Medicine, Bunkyo-ku, Japan, 21Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea, 22Instituto de Parasitología y Biomedicina López-Neyra, IPBLN-CSIC, PTS-Granada, Granada, Spain, 23Centro de Genomica e Investigación Oncológica, Pfizer-University of Granada-Junta de Andalucía, Granada, Spain, 24Department of Physiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey, 25Hospital Universitario Virgen del Rocío (IBiS,CSIC,US), Sevilla, Spain, 26Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Behcet's syndrome, Immunogenetics and genetics

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Vasculitis III: Pathogenic Mechanisms

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose:  Behçet’s disease is a chronic relapsing inflammatory disease characterized by recurrent mucocutaneous involvement. We performed dense genotyping in immune related loci in a large multi-ethnic cohort of Behçet’s disease patients and controls to further characterize the genetic basis of this disease.

Methods:  We studied 5 independent cohorts of Behçet’s disease patients and controls consisting of 1253 patients and 5799 controls from Turkey, Italy, Spain, Japan, and Korea. Genotyping was performed using the Immunochip platform (Illumina), which includes ~200,000 genetic variants in immune-related genetic loci. Genetic association analysis in each cohort and a meta-analysis were performed to identify genetic susceptibility loci for Behçet’s disease. Additional genetic variants were imputed up to the 1000 Genomes Project density. Conditional genetic analysis and functional mapping using epigenetic marks of enhancer regions and expression quantitative trait loci (eQTL) analyses were performed to further characterize the genetic effects identified.

Results:  We identified and fine-mapped genetic associations for Behçet’s disease with a GWAS level of significance in a lncRNA near QSOX2 (OR= 1.82, P= 1.08E-8), RASIP1/FUT2 (OR= 1.41, P= 3.57E-09), and IL12A-AS1 (OR= 1.71, P= 4.19E-08). The genetic association within the RASIP1/FUT2 locus is located within an active enhancer region as indicated by H3K27 acetylation marks. The disease risk variant in this locus is associated with mRNA expression changes of multiple transcripts within this locus, including significantly increased expression of RASIP1 and decreased expression of FUT2 in mucocutaneous tissues, frequently a target in Behçet’s disease. The association in the QSOX2 genetic locus can be localized to genetic variants within WI2-1959D15.1, which is a 1235bp lncRNA, and is associated with increased expression of this transcript. Several previously identified susceptibility loci for Behçet’s disease were also replicated.

Conclusion:  We performed dense genotyping in immune-related genes in a multi-ethnic cohort of Behçet’s disease patients and controls, and identified a novel genetic susceptibility locus in a lncRNA near QSOX2, a genetic association with a functional genetic variant within an enhancer region in RASIP1/FUT2, and replicated the recently reported association in IL12A-AS1.


Disclosure: P. Renauer, None; P. Coit, None; T. Hughes, None; M. Ognenovski, None; A. Adler, None; L. Ortiz-Fernández, None; V. Yilmaz, None; K. Aksu, None; N. Duzgun, None; G. Keser, None; A. Cefle, None; A. Yazici, None; A. Ergen, None; E. Alpsoy, None; C. Salvarani, None; B. Casali, None; I. Koetter, None; A. Zhernakova, None; C. Wijmenga, None; F. Takeuchi, None; S. Harihara, None; T. Kaburaki, None; Y. W. Song, None; F. D. Carmona, None; M. E. Alarcon Riquelme, None; J. Martín, None; G. Saruhan-Direskeneli, None; M. F. Gonzalez Escribano, None; H. Direskeneli, None; A. H. Sawalha, None.

To cite this abstract in AMA style:

Renauer P, Coit P, Hughes T, Ognenovski M, Adler A, Ortiz-Fernández L, Yilmaz V, Aksu K, Duzgun N, Keser G, Cefle A, Yazici A, Ergen A, Alpsoy E, Salvarani C, Casali B, Koetter I, Zhernakova A, Wijmenga C, Takeuchi F, Harihara S, Kaburaki T, Song YW, Carmona FD, Alarcon Riquelme ME, Martín J, Saruhan-Direskeneli G, Gonzalez Escribano MF, Direskeneli H, Sawalha AH. Dense Genotyping of Immune Related Loci in a Multi-Ethnic Behçet’s Disease Cohort Identifies Genetic Associations in a Long Noncoding RNA Near QSOX2, RASIP1/FUT2, and IL12A-AS1 [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/dense-genotyping-of-immune-related-loci-in-a-multi-ethnic-behcets-disease-cohort-identifies-genetic-associations-in-a-long-noncoding-rna-near-qsox2-rasip1fut2-and-il12a-as1/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dense-genotyping-of-immune-related-loci-in-a-multi-ethnic-behcets-disease-cohort-identifies-genetic-associations-in-a-long-noncoding-rna-near-qsox2-rasip1fut2-and-il12a-as1/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology